MedPath

Haemodynamic response to intubation

Phase 2/3
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2023/05/052837
Lead Sponsor
M REETHM
Brief Summary

Laryngoscopy and tracheal intubation are commonly used for airway management during general anesthesia.Propofol and ketamine are commonly used as an induction agents. Propofol has cardiovascular and respiratory depressant side effects whereas ketamine stimulates the cardiovascular system elevating heart rate, blood pressure and cardiac output.We hypothesise that combination of propofol-ketamine provides better Haemodynamic stability when compared to propofol and ketamine alone because of its distinct pharmacodynamic properties

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

1.Patients undergoing elective surgery under general anesthesia and with valid consent 2.ASA grade 1 and 2 patients.

Exclusion Criteria

1.Emergency surgeries 2.Prior sensitization or allergic reaction to propofol, ketamine, soy or egg products hemodynamic instability 3.Head injury 4.Increased intracranial or intraocular pressure 5.Pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Haemodynamic stability in terms of systolic blood pressure, diastolic blood pressure and mean arterial pressure are maintained when patient is induced with ketofol (combination of propofol and ketamine ) rather than when used alone as an induction agentsBaseline , 1 minute ,3minutes , 5 minutes ,15 minutes after intubation
Secondary Outcome Measures
NameTimeMethod
Decrease in post operative nausea and vomiting and decreased incidence of hallucinationsImmediately after extubation, 15 minutes , 30 minutes and 1 hour after extubation

Trial Locations

Locations (1)

NIMS HOSPITAL

🇮🇳

Hyderabad, TELANGANA, India

NIMS HOSPITAL
🇮🇳Hyderabad, TELANGANA, India
Dr REETHM
Principal investigator
9398188515
Reethammuddamalla@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.